Artificial bladder and manufacturing process
The invention consists of a multilayered device whose conformation allows to have a non-polymeric internal layer with high resistance to urine
The invention consists of a multilayered device whose conformation allows to have a non-polymeric internal layer with high resistance to urine
The invention concerns the use of DNA aptamers that can shield the SARS-CoV-2 binding site on the cell, and halt the cell-to-cell spreading of coronavirus.
The research focus has been on developing a method and an apparatus for in vitro three-dimensional cell co-culture
The invention proposes a new approach to rare genetic diseases for which no cures are available, only symptomatic treatments through the preparation of novel multivalent molecules active toward the human enzymes responsible for them
The invention relates to the use of beta-blocking compounds, in particular the antagonist of ?3 adrenoceptor (?3-ARs), for the treatment of immune-tolerance associated with pathological states, such as cancer.
The invention is represented by a mixture of molecules, called A_ATROFI, capable of regulating the balance between protein synthesis and its degradation in skeletal muscle cells.
The innovative method to diagnose uroperitoneum involves determining the concentration of a biomarker, Uromodulin, in a sample taken from abdominal drainage.
The invention describes a method for the diagnosis of neurodegenerative diseases based on the measurement, in a peripheral blood sample, of ?-synuclein heteromeric complexes with ?-amyloid or Tau protein.
The patented invention relates to techniques for fabricating composite polymer microstructures and not applicable to the field of Textile Engineering.
The patented invention relates to the micro-fabrication of imprinted polymeric structures with well-defined geometry for the fabrication of bioactive scaffolds. The scaffolds can be used both as substrates for the study and fabrication of functional tissue substitutes and as biosensors.